Fluvoxamine
(LFMYNZPAVPMEGP-PIDGMYBPSA-N)
Structure
- SMILES
- OC(=O)/C=C\C(=O)O.NCCO/N=C(/c1ccc(cc1)C(F)(F)F)\CCCCOC
- Molecular Formula:
- C19H25F3N2O6
- Molecular Weight:
- 434.407
- Log P:
- 3.6136
- Hydrogen Bond Acceptor:
- 8
- Hydrogen Bond Donor:
- 3
- TPSA:
- 131.44
- CAS Number(s):
- 54739-18-3; 54739-20-7; 61718-82-9
Synonym(s)
1.
Fluvoxamine
2.
DU-23000
3.
Desiflu
4.
Dumirox
5.
Faverin
6.
Fevarin
7.
Floxyfral
8.
Fluvoxadura
9.
Fluvoxamin AL
10.
Fluvoxamin Stada
11.
Fluvoxamin beta
12.
Fluvoxamin-neuraxpharm
13.
Fluvoxamin-ratiopharm
14.
Fluvoxamina Geminis
15.
Fluvoxamine Maleate
16.
Fluvoxamine Maleate, (E)-Isomer
17.
Fluvoxamine, (Z)-Isomer
18.
Luvox
19.
Novo-Fluvoxamine
20.
Nu-Fluvoxamine
21.
PMS-Fluvoxamine
22.
ratio-Fluvoxamine
23.
DU 23000
24.
DU23000
25.
Fluvoxamin neuraxpharm
26.
Fluvoxamin ratiopharm
27.
Geminis, Fluvoxamina
28.
Novo Fluvoxamine
29.
Nu Fluvoxamine
30.
PMS Fluvoxamine
31.
ratio Fluvoxamine
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Anxiety | FAERS: 14 | US FAERS | |
| 2 | Drug exposure during pregnancy | FAERS: 10 | US FAERS | |
| 3 | Drug ineffective | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 4 | Fatigue | FAERS: 8 | US FAERS | |
| 5 | Tremor | FAERS: 8 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 6 | Agitation | FAERS: 7 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 7 | Crying | FAERS: 7 | US FAERS | |
| 8 | Feeling abnormal | FAERS: 7 | US FAERS | |
| 9 | Asthenia | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 10 | Drug withdrawal syndrome | FAERS: 6 | US FAERS | |
| 11 | Nausea | FAERS: 6 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 12 | Neuroleptic Malignant Syndrome | FAERS: 6 | US FAERS | |
| 13 | Somnolence | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 14 | Suicide attempt | FAERS: 6 | US FAERS | |
| 15 | Vomiting | FAERS: 6 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 16 | Dizziness | FAERS: 5 | US FAERS | |
| 17 | Maternal exposure during pregnancy | FAERS: 5 | US FAERS | |
| 18 | Product substitution issue | FAERS: 5 | US FAERS | |
| 19 | Serotonin Syndrome | FAERS: 5 | US FAERS | |
| 20 | Completed Suicide | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 21 | Double Outlet Right Ventricle | FAERS: 4 | US FAERS | |
| 22 | Headache | FAERS: 4 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 23 | Malaise | FAERS: 4 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 24 | Obsessive-Compulsive Disorder | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 25 | Physical assault | FAERS: 4 | US FAERS | |
| 26 | Tachycardia | FAERS: 4 | US FAERS | |
| 27 | Abdominal Pain | FAERS: 3 | US FAERS | |
| 28 | Abdominal discomfort | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 29 | Akathisia | FAERS: 3 | US FAERS | |
| 30 | Altered state of consciousness | FAERS: 3 | US FAERS | |
| 31 | Cardiac Arrest | FAERS: 3 | US FAERS | |
| 32 | Chest Pain | FAERS: 3 | US FAERS | |
| 33 | Overdose | FAERS: 3 | US FAERS | |
| 34 | Pain | FAERS: 3 | US FAERS | |
| 35 | Restlessness | FAERS: 3 | US FAERS | |
| 36 | Accidental exposure | FAERS: 2 | US FAERS | |
| 37 | Alanine Aminotransferase Increased | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 38 | Anger | FAERS: 2 | US FAERS | |
| 39 | Blood creatine phosphokinase increased | FAERS: 2 | US FAERS | |
| 40 | Chills | FAERS: 2 | US FAERS | |
| 41 | Cold sweat | FAERS: 2 | US FAERS | |
| 42 | Craniosynostosis | FAERS: 2 | US FAERS | |
| 43 | Depressed Level of Consciousness | FAERS: 2 | US FAERS | |
| 44 | Depressed mood | FAERS: 2 | US FAERS | |
| 45 | Device dislocation | FAERS: 2 | US FAERS | |
| 46 | Diabetes Mellitus | FAERS: 2 | US FAERS | |
| 47 | Disease recurrence | FAERS: 2 | US FAERS | |
| 48 | Dissociation | FAERS: 2 | US FAERS | |
| 49 | Drug toxicity | FAERS: 2 | US FAERS | |
| 50 | Erythema Multiforme | FAERS: 2 | US FAERS | |
| 51 | Limb injury | FAERS: 2 | US FAERS | |
| 52 | Medication Error | FAERS: 2 | US FAERS | |
| 53 | Mydriasis | FAERS: 2 | US FAERS | |
| 54 | Neonatal disorder | FAERS: 2 | US FAERS | |
| 55 | Paranoia | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 56 | Poor quality sleep | FAERS: 2 | US FAERS | |
| 57 | Product dispensing error | FAERS: 2 | US FAERS | |
| 58 | Product quality issue | FAERS: 2 | US FAERS | |
| 59 | Status Epilepticus | FAERS: 2 | US FAERS | |
| 60 | Tinnitus | FAERS: 2 | US FAERS | |
| 61 | Unevaluable event | FAERS: 2 | US FAERS | |
| 62 | Accidental drug intake by child | FAERS: 1 | US FAERS | |
| 63 | Adverse event | FAERS: 1 | US FAERS | |
| 64 | Alopecia | FAERS: 1 | US FAERS | |
| 65 | Anuria | FAERS: 1 | US FAERS | |
| 66 | Arthralgia | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 67 | Aspartate Aminotransferase Increased | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 68 | Bipolar Disorder | FAERS: 1 | US FAERS | |
| 69 | Blood lactate dehydrogenase increased | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 70 | Blood potassium decreased | FAERS: 1 | US FAERS | |
| 71 | Burning sensation | FAERS: 1 | US FAERS | |
| 72 | Chest discomfort | FAERS: 1 | US FAERS | |
| 73 | Choking | FAERS: 1 | US FAERS | |
| 74 | Complications of maternal exposure to therapeutic drugs | FAERS: 1 | US FAERS | |
| 75 | Constipation | FAERS: 1 | US FAERS | |
| 76 | Deafness | FAERS: 1 | US FAERS | |
| 77 | Dementia | FAERS: 1 | US FAERS | |
| 78 | Device computer issue | FAERS: 1 | US FAERS | |
| 79 | Diplopia | FAERS: 1 | US FAERS | |
| 80 | Disability | FAERS: 1 | US FAERS | |
| 81 | Drug Dependence | FAERS: 1 | US FAERS | |
| 82 | Drug abuse | FAERS: 1 | US FAERS | |
| 83 | Drug dispensing error | FAERS: 1 | US FAERS | |
| 84 | Drug dose omission | FAERS: 1 | US FAERS | |
| 85 | Duodenal Ulcer | FAERS: 1 | US FAERS | |
| 86 | Dysgeusia | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 87 | Electrocardiogram abnormal | FAERS: 1 | US FAERS | |
| 88 | Electroencephalogram abnormal | FAERS: 1 | US FAERS | |
| 89 | Electromechanical dissociation | FAERS: 1 | US FAERS | |
| 90 | Erythema | FAERS: 1 | US FAERS | |
| 91 | Frustration | FAERS: 1 | US FAERS | |
| 92 | Hostility | FAERS: 1 | US FAERS | |
| 93 | Hyperacusis | FAERS: 1 | US FAERS | |
| 94 | Hypomania | FAERS: 1 | US FAERS | |
| 95 | Impaired driving ability | FAERS: 1 | US FAERS | |
| 96 | Inappropriate schedule of drug administration | FAERS: 1 | US FAERS | |
| 97 | Incorrect dose administered | FAERS: 1 | US FAERS | |
| 98 | Incorrect drug dosage form administered | FAERS: 1 | US FAERS | |
| 99 | Influenza | FAERS: 1 | US FAERS | |
| 100 | Intentional product use issue | FAERS: 1 | US FAERS | |
| 101 | Intertrigo | FAERS: 1 | US FAERS | |
| 102 | Intestinal Obstruction | FAERS: 1 | US FAERS | |
| 103 | Leukocytoclastic vasculitis | FAERS: 1 | US FAERS | |
| 104 | Long QT Syndrome | FAERS: 1 | US FAERS | |
| 105 | Male Orgasmic Disorder | FAERS: 1 | US FAERS | |
| 106 | Medical device complication | FAERS: 1 | US FAERS | |
| 107 | Menorrhagia | FAERS: 1 | US FAERS | |
| 108 | Metabolic acidosis | FAERS: 1 | US FAERS | |
| 109 | Mitochondrial enzyme deficiency | FAERS: 1 | US FAERS | |
| 110 | Murder | FAERS: 1 | US FAERS | |
| 111 | Musculoskeletal stiffness | FAERS: 1 | US FAERS | |
| 112 | Myalgia | FAERS: 1 | US FAERS | |
| 113 | No adverse event | FAERS: 1 | US FAERS | |
| 114 | Occult blood positive | FAERS: 1 | US FAERS | |
| 115 | Opisthotonus | FAERS: 1 | US FAERS | |
| 116 | Otosclerosis | FAERS: 1 | US FAERS | |
| 117 | Palpitations | FAERS: 1 | US FAERS | |
| 118 | Pericardial effusion | FAERS: 1 | US FAERS | |
| 119 | Personality Change | FAERS: 1 | US FAERS | |
| 120 | Pharyngitis | FAERS: 1 | US FAERS | |
| 121 | Placental Insufficiency | FAERS: 1 | US FAERS | |
| 122 | Pneumonia | FAERS: 1 | US FAERS | |
| 123 | Pregnancy | FAERS: 1 | US FAERS | |
| 124 | Prescribed overdose | FAERS: 1 | US FAERS | |
| 125 | Product availability issue | FAERS: 1 | US FAERS | |
| 126 | Product use in unapproved indication | FAERS: 1 | US FAERS | |
| 127 | Pruritus | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 128 | Pulmonary Valve Stenosis | FAERS: 1 | US FAERS | |
| 129 | Respiratory Failure | FAERS: 1 | US FAERS | |
| 130 | Restless Legs Syndrome | FAERS: 1 | US FAERS | |
| 131 | Retching | FAERS: 1 | US FAERS | |
| 132 | Rhabdomyolysis | FAERS: 1 | US FAERS | |
| 133 | Schizophrenia | FAERS: 1 | US FAERS | |
| 134 | Screaming | FAERS: 1 | US FAERS | |
| 135 | Spousal Abuse | FAERS: 1 | US FAERS | |
| 136 | Stress | FAERS: 1 | US FAERS | |
| 137 | Tension Headache | FAERS: 1 | US FAERS | |
| 138 | Tongue movement disturbance | FAERS: 1 | US FAERS | |
| 139 | Tonsillitis | FAERS: 1 | US FAERS | |
| 140 | Toxicity to various agents | FAERS: 1 | US FAERS | |
| 141 | Weight decreased | FAERS: 1 | US FAERS | |
| 142 | Yawning | FAERS: 1 | US FAERS | |
| 143 | Blood alkaline phosphatase increased | Canada Vigilance: 1 | Canada Vigilance | |
| 144 | Blood creatinine increased | Canada Vigilance: 1 | Canada Vigilance | |
| 145 | Blood urea increased | Canada Vigilance: 1 | Canada Vigilance | |
| 146 | Bradycardia | Canada Vigilance: 1 | Canada Vigilance | |
| 147 | Cataract | Canada Vigilance: 1 | Canada Vigilance | |
| 148 | Delirium | Canada Vigilance: 1 | Canada Vigilance | |
| 149 | Dystonia | Canada Vigilance: 1 | Canada Vigilance | |
| 150 | Ecchymosis | Canada Vigilance: 1 | Canada Vigilance | |
| 151 | Enuresis | Canada Vigilance: 1 | Canada Vigilance | |
| 152 | Executive dysfunction | Canada Vigilance: 1 | Canada Vigilance | |
| 153 | Gamma-Glutamyltransferase Increased | Canada Vigilance: 1 | Canada Vigilance | |
| 154 | Head discomfort | Canada Vigilance: 1 | Canada Vigilance | |
| 155 | Hirsutism | Canada Vigilance: 1 | Canada Vigilance | |
| 156 | Neutropenia | Canada Vigilance: 1 | Canada Vigilance | |
| 157 | Oppositional Defiant Disorder | Canada Vigilance: 1 | Canada Vigilance | |
| 158 | Pyelonephritis | Canada Vigilance: 1 | Canada Vigilance | |
| 159 | Tardive Dyskinesia | Canada Vigilance: 1 | Canada Vigilance | |
| 160 | Urinary Retention | Canada Vigilance: 2 | Canada Vigilance | |
| 161 | Urinary assistance device user | Canada Vigilance: 1 | Canada Vigilance | |
| 162 | Vertigo | Canada Vigilance: 2 | Canada Vigilance | |
| 163 | jaundice | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.